ABCG2 and glioblastoma: In contrast, specific MRP1 knockdown or treatment with MK-571 did not affect the temozolomide-induced response in GBM cells, which was in concordance with previous findings, illustrating that temozolomide is a substrate for P-gp and Breast Cancer Resistance Protein (BCRP) but not MRP1 [134].